Suchergebnisse - "Benzhydryl Compounds/adverse effects"
-
1
Autoren: et al.
Quelle: Circulation. 146(16):1210-1224
Schlagwörter: *Benzhydryl Compounds/adverse effects, *Frailty/epidemiology, *Glucosides/adverse effects, *Heart Failure/drug therapy, clinical trial, dapagliflozin, frailty, heart failure, Humans, Quality of Life, Stroke Volume
Dateibeschreibung: print
-
2
Autoren: et al.
Quelle: Adv Ther
Schlagwörter: Male, Heart Failure, ddc:610, Middle Aged, Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Randomized Controlled Trials as Topic [MeSH], Hypoglycemic Agents/adverse effects [MeSH], Male [MeSH], Adverse drug event, Hypoglycemic Agents/therapeutic use [MeSH], Glucosides/adverse effects [MeSH], Original Research, SGLT2 inhibitors, Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Adverse drug reaction, Female [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Diabetes Mellitus, Type 2/complications [MeSH], Humans [MeSH], Drug safety, Cardiovascular Diseases [MeSH], Heart Failure [MeSH], Middle Aged [MeSH], Renal Insufficiency, Chronic [MeSH], Glucosides/therapeutic use [MeSH], Empagliflozin, Glucosides, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Humans, Hypoglycemic Agents, Female, Benzhydryl Compounds, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Aged, Randomized Controlled Trials as Topic
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38771475
https://repository.publisso.de/resource/frl:6508947
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-398088
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/39808
https://doi.org/10.1007/s12325-024-02879-w
https://opus.bibliothek.uni-wuerzburg.de/files/39808/12325_2024_Article_2879.pdf -
3
Autoren: et al.
Quelle: Clin Exp Nephrol
Schlagwörter: Male, Kidney, 01 natural sciences, 03 medical and health sciences, 0302 clinical medicine, Glucosides, Japan, Double-Blind Method, Humans, Albuminuria, Renal Insufficiency, Chronic, Benzhydryl Compounds, 0101 mathematics, Sodium-Glucose Transporter 2 Inhibitors, Aged, Middle Aged, 16. Peace & justice, 3. Good health, Treatment Outcome, Cardiovascular Diseases, Disease Progression, Benzhydryl Compounds/therapeutic use [MeSH], Double-Blind Method [MeSH], Kidney/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Renal Insufficiency, Chronic/physiopathology [MeSH], Disease Progression [MeSH], Renal Insufficiency, Chronic/diagnosis [MeSH], Aged [MeSH], Cardiovascular disease, Kidney/physiopathology [MeSH], Male [MeSH], Glucosides/adverse effects [MeSH], Glomerular Filtration Rate/drug effects [MeSH], Kidney Failure, Chronic/drug therapy [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Female [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Humans [MeSH], Albuminuria/drug therapy [MeSH], Treatment Outcome [MeSH], Cardiovascular Diseases [MeSH], Middle Aged [MeSH], Japan/epidemiology [MeSH], Glucosides/therapeutic use [MeSH], Kidney function, Rapid Communication, Randomised trial, Sodium–glucose co-transporter-2 inhibitor, Renal Insufficiency, Chronic/drug therapy [MeSH], Kidney Failure, Chronic, Female, Glomerular Filtration Rate
-
4
Autoren: et al.
Quelle: Anaesthesiologie
Schlagwörter: Kasuistiken, Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Cardiac Surgical Procedures/adverse effects [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Ketosis/chemically induced [MeSH], Postoperative Complications/drug therapy [MeSH], Aged [MeSH], Humans [MeSH], Glucosides/therapeutic use [MeSH], Male [MeSH], Glucosides/adverse effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH]
Zugangs-URL: https://repository.publisso.de/resource/frl:6522254
-
5
Autoren: et al.
Quelle: Vernstrøm, L, Gullaksen, S, Sørensen, S S, Funck, K L, Laugesen, E & Poulsen, P L 2024, 'Separate and combined effects of empagliflozin and semaglutide on vascular function : A 32-week randomized trial', Diabetes, Obesity and Metabolism, vol. 26, no. 5, pp. 1624-1635. https://doi.org/10.1111/dom.15464
Schlagwörter: Blood Glucose, Diabetes Mellitus, Type 2/complications, Blood Glucose Self-Monitoring, Benzhydryl Compounds/adverse effects, macrovascular disease, Glucagon-Like Peptides, Pulse Wave Analysis, glucagon-like peptide-1 analogue, sodium–glucose cotransporter 2 inhibitor, Hypoglycemic Agents/adverse effects, 3. Good health, Treatment Outcome, Diabetes Mellitus, Type 2, Double-Blind Method, Glucosides, Creatinine, Albumins, drug mechanism, Humans, Hypoglycemic Agents, continuous glucose monitoring, type 2 diabetes, Benzhydryl Compounds
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38240066
https://pure.au.dk/portal/en/publications/2dd5d1f7-508b-4be5-be82-9aff7f290893
https://pure.au.dk/portal/en/publications/2dd5d1f7-508b-4be5-be82-9aff7f290893
http://www.scopus.com/inward/record.url?scp=85182704727&partnerID=8YFLogxK
https://doi.org/10.1111/dom.15464
https://pure.au.dk/ws/files/434166896/Diabetes_Obesity_Metabolism_-_2024_-_Vernstr_m_-_Separate_and_combined_effects_of_empagliflozin_and_semaglutide_on_vascular.pdf -
6
Autoren: et al.
Quelle: Circulation Heart Failure. 14(12)
Schlagwörter: Aged, Atrial Fibrillation/drug therapy/physiopathology, Benzhydryl Compounds/*adverse effects/*therapeutic use, clinical trials, Clinical Trials as Topic, Glucosides/*adverse effects/*therapeutic use, heart failure with reduced ejection fraction, Heart Failure/*drug therapy/physiopathology, Hospitalization/statistics & numerical data, Humans, Male, Middle Aged, Natriuretic Peptide, Brain/*therapeutic use, natriuretic peptides, Peptide Fragments/*therapeutic use, sodium-glucose cotransporter 2 inhibitors, Stroke Volume/drug effects, Ventricular Function, Left/drug effects
Dateibeschreibung: print
-
7
Autoren: et al.
Quelle: Jürgens, M, Schou, M, Hasbak, P, Kjær, A, Wolsk, E, Zerahn, B, Brandt-Jacobsen, N H, Gæde, P, Rossing, P, Faber, J, Inzucchi, S E, Gustafsson, F & Kistorp, C 2023, ' The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes ', Diabetes, Obesity and Metabolism, vol. 25, no. 10, pp. 2888-2896 . https://doi.org/10.1111/dom.15183
Schlagwörter: Cardiovascular Diseases/epidemiology, Benzhydryl Compounds/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, heart failure, SGLT2 inhibitor, Type 2/complications, GFR, 3. Good health, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Diabetes Mellitus, Humans, type 2 diabetes, extracellular volume, Plasma Volume, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, plasma volume, Glomerular Filtration Rate
Dateibeschreibung: application/pdf
-
8
Autoren: et al.
Quelle: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-7 (2024)Schlagwörter: Male, Time Factors, Myocardial Infarction, Risk Assessment, 03 medical and health sciences, Diabetes mellitus, 0302 clinical medicine, Glucosides, Risk Factors, Recurrence, Sodium-glucose transporter 2 inhibitors, Diseases of the circulatory (Cardiovascular) system, Humans, Myocardial infarction, Type 2, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Aged, Research, Middle Aged, 3. Good health, Benzhydryl Compounds/therapeutic use [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Risk Assessment [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Risk Factors [MeSH], Diabetes Mellitus, Type 2/mortality [MeSH], Male [MeSH], Myocardial Infarction/diagnosis [MeSH], Glucosides/adverse effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Female [MeSH], Myocardial Infarction/mortality [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Diabetes Mellitus, Type 2/complications [MeSH], Myocardial Infarction/prevention, Humans [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Recurrence [MeSH], Myocardial Infarction/epidemiology [MeSH], Glucosides/therapeutic use [MeSH], Treatment Outcome, Diabetes Mellitus, Type 2, RC666-701, Female
-
9
Autoren: et al.
Weitere Verfasser: et al.
Quelle: N Engl J Med
Docusalut
Conselleria de Salut i Consum del Govern de les Illes BalearsSchlagwörter: Chronic/complications, Insuficiencia Renal Crónica, Progresión de la Enfermedad, Benzhydryl Compounds/adverse effects, Empagliflozin, Riñón, Diabetes Mellitus Tipo 2, Kidney, Article, 03 medical and health sciences, Cardiology, Chronic Kidney Disease, Clinical Medicine, Clinical Medicine General, Diabetes, Endocrinology, Nephrology, Prevention, 0302 clinical medicine, Creatinine/urine, Diabetes Mellitus, Humans, Renal Insufficiency, Benzhydryl Compounds, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Enfermedades Cardiovasculares, 2. Zero hunger, Compuestos de Bencidrilo, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Tasa de Filtración Glomerular, Cardiovascular Diseases/chemically induced, Type 2/complications, Humanos, 3. Good health, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Inhibidores del Cotransportador de Sodio-Glucosa 2, Creatinine, Disease Progression, Creatinina, empagliflozin, chronic renal disease, empa-kidney, chronic kidney disease, proteinuria, empagliflozin, Kidney/physiopathology, Glomerular Filtration Rate
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36331190
http://hdl.handle.net/20.500.13003/18576
https://hdl.handle.net/20.500.13003/18576
https://ora.ox.ac.uk/objects/uuid:f91f9722-f207-4d97-aa64-58636b323acc
https://doi.org/10.1056/nejmoa2204233
https://hdl.handle.net/11573/1674927
https://doi.org/10.1056/NEJMoa2204233 -
10
Autoren: et al.
Quelle: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-12 (2024)Schlagwörter: Male, Time Factors, Linagliptin, Pulse Wave Analysis, Kidney, 03 medical and health sciences, Vascular Stiffness, 0302 clinical medicine, Glucosides, Diseases of the circulatory (Cardiovascular) system, Humans, Insulin, Diabetic Nephropathies, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Aged, PWV, Research, Middle Aged, Metformin, 3. Good health, Treatment Outcome, Diabetes Mellitus, Type 2, RC666-701, GFR decline, Female, Drug Therapy, Combination, Benzhydryl Compounds/therapeutic use [MeSH], Kidney/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Diabetic Nephropathies/diagnosis [MeSH], Diabetes Mellitus, Type 2/physiopathology [MeSH], Sodium-Glucose Transporter 2 [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Metformin/therapeutic use [MeSH], Kidney/physiopathology [MeSH], Hypoglycemic Agents/adverse effects [MeSH], Male [MeSH], Hypoglycemic Agents/therapeutic use [MeSH], Glucosides/adverse effects [MeSH], Clinical Relevance [MeSH], Drug Therapy, Combination [MeSH], SGLT2 inhibitors, Glomerular Filtration Rate/drug effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Diabetes Mellitus, Type 2/diagnosis [MeSH], Female [MeSH], Linagliptin/therapeutic use [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Insulin [MeSH], Linagliptin/adverse effects [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Diabetic Nephropathies/physiopathology [MeSH], Glucosides/therapeutic use [MeSH], Diabetic Nephropathies/drug therapy [MeSH], Pulse Wave Analysis [MeSH], Vascular Stiffness/drug effects [MeSH], Glomerular Filtration Rate
-
11
Autoren: et al.
Quelle: New England Journal of Medicine. 387(12):1089-1098
Schlagwörter: *Heart Failure/complications/drug therapy/mortality/physiopathology, *Sodium-Glucose Transporter 2 Inhibitors/adverse effects/pharmacology/therapeutic use, *Stroke Volume/drug effects, *Ventricular Function, Left/drug effects, Benzhydryl Compounds/adverse effects/therapeutic use, Diabetes Mellitus, Type 2/complications/drug therapy, Glucosides/adverse effects/therapeutic use, Humans
Dateibeschreibung: print
-
12
Autoren: et al.
Quelle: DAPA-CKD Trial Committees and Investigators 2021, ' Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease : a prespecified analysis from the DAPA-CKD trial ', The Lancet Diabetes and Endocrinology, vol. 9, no. 1, pp. 22-31 . https://doi.org/10.1016/S2213-8587(20)30369-7
Schlagwörter: Adult, Male, Chronic/complications, Benzhydryl Compounds/adverse effects, Kidney/drug effects, Kidney, Glucosides/adverse effects, Kidney Failure, 03 medical and health sciences, Chronic/chemically induced, 0302 clinical medicine, Double-Blind Method, Glucosides, Diabetes Mellitus, Humans, Diabetic Nephropathies, Renal Insufficiency, Benzhydryl Compounds, Renal Insufficiency, Chronic, Heart Failure/chemically induced, Aged, Heart Failure, Middle Aged, Cardiovascular Diseases/chemically induced, 16. Peace & justice, Type 2/complications, 3. Good health, Treatment Outcome, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Diabetic Nephropathies/drug therapy, Kidney Failure, Chronic, Female
Dateibeschreibung: application/pdf
Zugangs-URL: https://pure.rug.nl/ws/files/174052406/Effects_of_dapagliflozin_on_major_adverse_kidney_and_cardiovascular_events_in_patients_with_diabetic_and_non_diabetic_chronic_kidney_disease_a_prespecified_analysis_from_the_DAPA_CKD_trial.pdf
https://pubmed.ncbi.nlm.nih.gov/33338413
https://hdl.handle.net/11370/92ee2074-5922-4044-aceb-cfcbddfff59c
https://research.rug.nl/en/publications/92ee2074-5922-4044-aceb-cfcbddfff59c
https://doi.org/10.1016/S2213-8587(20)30369-7
https://utsouthwestern.pure.elsevier.com/en/publications/effects -of-dapagliflozin-on-major-adverse -kidney-and-cardiovascul
https://www.sciencedirect.com/science/article/abs/pii/S2213858720303697
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(20)30369-7/fulltext
https://pure.rug.nl/ws/files/174052406/Effects_of_dapagliflozin_on_major_adverse_kidney_and_cardiovascular_events_in_patients_with_diabetic_and_non_diabetic_chronic_kidney_disease_a_prespecified_analysis_from_the_DAPA_CKD_trial.pdf
https://www.ncbi.nlm.nih.gov/pubmed/33338413
https://europepmc.org/article/MED/33338413
https://curis.ku.dk/ws/files/312334945/Wheeler_DAPA_CKD_Diabetes_and_CKD_aetiology_Revd_Ms_Clean_REVISED15OCT.pdf
https://discovery-pp.ucl.ac.uk/id/eprint/10122004/ -
13
Autoren: et al.
Quelle: Revue Médicale Suisse. 17:1034-1038
Schlagwörter: Benzhydryl Compounds / adverse effects, Heart Failure, 03 medical and health sciences, 0302 clinical medicine, Hypoglycemic Agents / adverse effects, Humans, Stroke Volume, Cardiovascular Diseases / chemically induced, Diabetes Mellitus, Type 2 / drug therapy, Sodium-Glucose Transporter 2 Inhibitors / therapeutic use
Dateibeschreibung: application/pdf
-
14
Autoren: et al.
Quelle: Dipòsit Digital de la UB
Universidad de Barcelona
Articles publicats en revistes (Ciències Clíniques)
instname
Heerspink, H J L, Stefánsson, B V, Correa-Rotter, R, Chertow, G M, Greene, T, Hou, F-F, Mann, J F E, McMurray, J J V, Lindberg, M, Rossing, P, Sjöström, C D, Toto, R D, Langkilde, A-M, Wheeler, D C & DAPA-CKD Trial Committees and Investigators 2020, 'Dapagliflozin in Patients with Chronic Kidney Disease', The New England Journal of Medicine, vol. 383, no. 15, pp. 1436-1446. https://doi.org/10.1056/NEJMoa2024816
Heerspink, H J L, Stefánsson, B V, Correa-Rotter, R, Chertow, G M, Greene, T, Hou, F-F, Mann, J F E, McMurray, J J V, Lindberg, M, Rossing, P, Sjöström, C D, Toto, R D, Langkilde, A-M, Wheeler, D C & DAPA-CKD Trial Committees and Investigators 2020, ' Dapagliflozin in Patients with Chronic Kidney Disease ', The New England Journal of Medicine, vol. 383, no. 15, pp. 1436-1446 . https://doi.org/10.1056/NEJMoa2024816Schlagwörter: Male, Chronic/complications, Kidney Failure, Chronic/mortality, Renal Insufficiency, Chronic/complications, Benzhydryl Compounds/adverse effects, Kaplan-Meier Estimate, Glomerular Filtration Rate/drug effects, CARDIOVASCULAR OUTCOMES, 01 natural sciences, Glucosides/adverse effects, 12. Responsible consumption, Kidney Failure, 03 medical and health sciences, 0302 clinical medicine, Glucosides, Diabetes Mellitus, Humans, Diabetic Nephropathies, Renal Insufficiency, Cardiovascular Diseases/etiology, Benzhydryl Compounds, Renal Insufficiency, Chronic, 0101 mathematics, Sodium-Glucose Transporter 2 Inhibitors, Aged, Diabetis, Kidney diseases, Diabetes Mellitus, Type 2/complications, Glucòsids, EMPAGLIFLOZIN, Diabetes, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Chronic/mortality, Middle Aged, 16. Peace & justice, Type 2/complications, 3. Good health, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Diabetic Nephropathies/drug therapy, Malalties del ronyó, Kidney Failure, Chronic, Regression Analysis, Female, Glomerular Filtration Rate
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/32970396
http://hdl.handle.net/2445/189959
https://hdl.handle.net/2445/189959
https://eprints.gla.ac.uk/223971/1/223971.pdf
https://research.rug.nl/en/publications/1def9c25-613d-4882-b619-e4099c6307a2
https://doi.org/10.1056/NEJMoa2024816
https://hdl.handle.net/11370/1def9c25-613d-4882-b619-e4099c6307a2
https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F1def9c25-613d-4882-b619-e4099c6307a2
https://utsouthwestern.pure.elsevier.com/en/publications/dapagliflozin-in-patients-with-chronic-kidney-disease
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2024816
https://discovery.ucl.ac.uk/id/eprint/10121440/
https://pubmed.ncbi.nlm.nih.gov/32970396/
https://research.rug.nl/en/publications/dapagliflozin-in-patients-with-chronic-kidney-disease
https://pure.au.dk/ws/files/219666327/Dapagliflozin_in_Patients_with_Chronic_Kidney_Disease.pdf
https://curis.ku.dk/ws/files/290114009/Dapagliflozin_in_Patients.pdf
https://discovery-pp.ucl.ac.uk/id/eprint/10111476/
https://pure.au.dk/ws/files/219666327/Dapagliflozin_in_Patients_with_Chronic_Kidney_Disease.pdf
https://pure.au.dk/portal/en/publications/a2f30671-4e80-4d28-854b-555d5576009b
https://doi.org/10.1056/NEJMoa2024816
http://www.scopus.com/inward/record.url?scp=85092598310&partnerID=8YFLogxK -
15
Autoren: et al.
Weitere Verfasser: et al.
Quelle: ISSN: 0160-4120 ; Environment International ; https://hal.science/hal-04416688 ; Environment International, 2023, 178, pp.108100. ⟨10.1016/j.envint.2023.108100⟩ ; https://www.sciencedirect.com/science/article/pii/S0160412023003732.
Schlagwörter: Chronic kidney disease, Dialysis, End stage renal disease, Endocrine disruptors, Exposure, Plasticizers, MESH: Benzhydryl Compounds / adverse effects, MESH: Dibutyl Phthalate, MESH: Diethylhexyl Phthalate, MESH: Endocrine Disruptors* / adverse effects, MESH: Humans, MESH: Phenols, MESH: Renal Dialysis, [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology, [SDV.EE.SANT]Life Sciences [q-bio]/Ecology, environment/Health, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Relation: info:eu-repo/semantics/altIdentifier/pmid/37481953; PUBMED: 37481953
-
16
Autoren: et al.
Schlagwörter: Adult, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/therapeutic use, Central Nervous System Stimulants/therapeutic use, Dose-Response Relationship, Drug, Fatigue/complications, Fatigue/drug therapy, Female, Humans, Male, Middle Aged, Multiple Sclerosis/complications, Neuropsychological Tests, Patient Selection, Psychiatric Status Rating Scales, Questionnaires, Severity of Illness Index, Sleep/drug effects, Stroke/complications, Treatment Outcome, Wakefulness/drug effects
Relation: European Neurology; 1421-9913[electronic]; https://iris.unil.ch/handle/iris/222916; serval:BIB_C3EECA832B45; 000268894400008
-
17
Autoren: et al.
Schlagwörter: Benzhydryl Compounds/therapeutic use, Benzhydryl Compounds/adverse effects, Benzhydryl Compounds/pharmacokinetics, Humans, Glucosides/therapeutic use, Glucosides/adverse effects, Glucosides/pharmacokinetics, Glucosides/pharmacology, Glucosides/administration & dosage, Child, Diabetes Mellitus, Type 2/drug therapy, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sodium-Glucose Transporter 2 Inhibitors/pharmacology, Adolescent
Relation: Pediatric Drugs; https://iris.unil.ch/handle/iris/145148; serval:BIB_89AC363D5E5F; 001205038800001
-
18
Autoren: et al.
Quelle: New England Journal of Medicine. 381:1995-2008
Schlagwörter: MECHANISM, Male, Benzhydryl Compounds/adverse effects, Kaplan-Meier Estimate, Cardiovascular Agents/therapeutic use, Glucosides/adverse effects, Glycated Hemoglobin A/analysis, NEPRILYSIN INHIBITION, Ventricular Dysfunction, Left, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Glucosides, Diabetes Mellitus, Ventricular Dysfunction, Humans, COTRANSPORTER 2 INHIBITORS, Benzhydryl Compounds, Cardiovascular Diseases/mortality, Sodium-Glucose Transporter 2 Inhibitors, Type 2/blood, Aged, Glycated Hemoglobin, Heart Failure, OUTCOMES, EMPAGLIFLOZIN, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Cardiovascular Agents, Stroke Volume, Middle Aged, Combined Modality Therapy, 3. Good health, Hospitalization, Heart Failure/complications, Diabetes Mellitus, Type 2, Left/complications, Cardiovascular Diseases, Combination, Stroke Volume/drug effects, Drug Therapy, Combination, Female
Dateibeschreibung: application/pdf
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/31535829
https://eprints.gla.ac.uk/197128/1/197128.pdf
https://research.rug.nl/en/publications/78f6f00c-dcec-48e8-84f2-30c398e42349
https://hdl.handle.net/11370/78f6f00c-dcec-48e8-84f2-30c398e42349
https://doi.org/10.1056/NEJMoa1911303
http://eprints.gla.ac.uk/197128/
https://www.nejm.org/doi/pdf/10.1056/NEJMoa1911303?articleTools=true
http://pubmed.ncbi.nlm.nih.gov/32130822/
https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2F78f6f00c-dcec-48e8-84f2-30c398e42349
https://cris.unibo.it/handle/11585/762696
http://www.diva-portal.org/smash/record.jsf?pid=diva2:1389277
https://www.nejm.org/doi/full/10.1056/NEJMoa1911303
https://doi.org/10.1056/NEJMoa1911303
https://acuresearchbank.acu.edu.au/item/8q12y/dapagliflozin-in-patients-with-heart-failure-and-reduced-ejection-fraction -
19
Autoren: et al.
Quelle: Journal of Perinatal Medicine. 47:765-770
Schlagwörter: Adult, occupational - chemistry, Phenols - chemistry, Birth weight - drug effects, Placenta, Phenols - blood, Benzhydryl compounds - adverse effects, Pregnancy trimester, Phenols - adverse effects, Air Pollutants, Occupational, non-steroidal - blood, 01 natural sciences, Gas Chromatography-Mass Spectrometry, Permeability, Phenols, Pregnancy, non-steroidal - chemistry, Birth Weight, Humans, Estrogens, Non-Steroidal, Amniotic fluid - chemistry, Benzhydryl Compounds, Maternal-Fetal Exchange, occupational - blood, 0105 earth and related environmental sciences, occupational - adverse effects, 2. Zero hunger, non-steroidal - adverse effects, Maternal exposure - prevention & control, Estrogens, Environmental Exposure, Amniotic Fluid, Benzhydryl compounds - chemistry, Placenta - physiopathology, second, 3. Good health, Gas chromatography-mass spectrometry - methods, Maternal Exposure, Pregnancy Trimester, Second, Female, Environmental exposure - prevention & control, Maternal-fetal exchange, Air pollutants, Benzhydryl compounds - blood
Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/31348763
https://www.ncbi.nlm.nih.gov/pubmed/31348763
https://europepmc.org/article/MED/31348763
https://www.degruyter.com/document/doi/10.1515/jpm-2019-0040/html
https://pubmed.ncbi.nlm.nih.gov/31348763/
https://www.degruyter.com/view/journals/jpme/47/7/article-p765.xml
https://doi.org/10.1515/jpm-2019-0040 -
20
Autoren: et al.
Quelle: Cardiovasc Diabetol
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-10 (2021)Schlagwörter: Male, Time Factors, Blood Pressure, 03 medical and health sciences, Vascular Stiffness, 0302 clinical medicine, Double-Blind Method, Glucosides, Germany, Diseases of the circulatory (Cardiovascular) system, Humans, ddc:610, Prospective Studies, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Original Investigation, Aged, Benzhydryl Compounds/therapeutic use [MeSH], Double-Blind Method [MeSH], Sodium-Glucose Transporter 2 Inhibitors/therapeutic use [MeSH], Aged [MeSH], Angiology, Up-Regulation [MeSH], 3-Hydroxybutyric Acid/blood [MeSH], Male [MeSH], Chronic Disease [MeSH], Cardiology, Glucosides/adverse effects [MeSH], Sodium-Glucose Transporter 2 Inhibitors/adverse effects [MeSH], Female [MeSH], Benzhydryl Compounds/adverse effects [MeSH], Biomarkers/blood [MeSH], Heart Failure/drug therapy [MeSH], Heart Failure/physiopathology [MeSH], Humans [MeSH], Prospective Studies [MeSH], Blood Pressure/drug effects [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Time Factors [MeSH], Diabetes, Glucosides/therapeutic use [MeSH], Germany [MeSH], Vascular Stiffness/drug effects [MeSH], Heart Failure/blood [MeSH], Heart Failure/diagnosis [MeSH], Heart Failure, 3-Hydroxybutyric Acid, Middle Aged, Up-Regulation, 3. Good health, Treatment Outcome, RC666-701, Chronic Disease, Female, Biomarkers
Dateibeschreibung: application/pdf
Zugangs-URL: https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-021-01410-7
https://pubmed.ncbi.nlm.nih.gov/34753480
https://doaj.org/article/b7b30358f28b414ca7ef3d20f55fd8c2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579532
https://cardiab.biomedcentral.com/articles/10.1186/s12933-021-01410-7
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/18119
https://repository.publisso.de/resource/frl:6462947
Full Text Finder 
Nájsť tento článok vo Web of Science 
Full Text